We provide you with 20 years of free, institutional-grade data for TELA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TELA. Explore the full financial landscape of TELA stock.
| Reported Date | CIK | Ticker | Type |
|---|
TELA Bio, Inc(NASDAQ:TELA) 
TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdomina...
Website: http://www.telabio.com
Founded: 2012
IPO Price: $13 (Nov 08, 2019)
Full Time Employees: 89
CEO: Antony Koblish
Sector: Healthcare
Industry: Medical Devices
Share this website to your friends
The information provided in this report about TELA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.